Taoufik Alsaadi

21PUBLICATIONS
53CO-AUTHORS
Traditional Chinese medicine and treatmentsEpidemiological methodsPrivacy and data rightsGene and molecular therapyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 19, 2026
Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE.

|Apr 22, 2026
Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3-Month results from the TRIUMPH study.

|Apr 09, 2026
Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry-Based Real-World Study.

Christian Lampl, Reem Suliman, Viktoria Tischler-Strasser

|Mar 31, 2026
Transcultural headache medicine: A framework for integrating cultural contexts into headache science and care - a call to action from the International Headache Society.

Mario F P Peres, Giancarlo Lucchetti, Homero Vallada

|Nov 13, 2025
Clinical factors associated with perampanel retention, response, seizure freedom and tolerability: real-world evidence from the PERMIT Extension study.

Taoufik Alsaadi, Patricia Penovich, Stéphane Auvin

|Jul 30, 2025
A randomized open-label study to evaluate the effectiveness and safety of once-daily rimegepant 75 mg orally disintegrating tablet for the short-term preventive treatment of fasting-triggered headache in individuals with migraine.

Taoufik Alsaadi, Reem Suliman, Jiyue Yang

Pageof 4

Frequent Collaborators

6 joint publications

Reem Suliman

5 joint publications

Eugen Trinka

3 joint publications

Elaine C Wirrell

3 joint publications

Rima Nabbout